solutions

Enrollment feasibility

Actionable insights that accelerate enrollment and time-to-market.

Design studies that strike the optimal balance between patient experience, site efficiency, and meeting your timelines.

Enrollment benchmarking

Our benchmarks scientifically assess how recruitable your protocol is in reality.

Using statistical modelling on external real-world trial datasets and proprietary data from supporting 2,500 studies, we allow clients to:

All this and more is powered by our enrollment intelligence platform, ClinSight.

How we assess the reality of your
protocol’s recruitment

The published science behind our enrollment benchmarking

Clariness’ models have been validated through peer-reviewed publications and
industry research, so you can trust the enrollment insights we deliver via ClinSight.

Our latest peer-reviewed papers

Proven: Data-driven channel selection accelerates enrollment for a mental health study

Published June 2025,
JMIR Mental Health

Verified: It is possible to reach unaware and undiagnosed patients in recruitment

Published Sep 2025,
JMIR Mental Health

Validated: Fully virtual recruitment performance vs. traditional studies

Published Aug 2025,
Taylor & Francis

Imagine your study’s enrollment potential
with scientifically validated insights that optimize every touchpoint?

Imagine having ClinSight.

Patient feasibility

Traditional feasibility creates funnel assumptions; our patient feasibility proves them.

Launching controlled, proof-of-concept campaigns aligned to your study’s site locations, we help clients:

Are you ready to transform funnel assumptions into enrollment certainties?

Get the complete enrollment picture,
with patient & site perspectives

Patient & site surveys

Validate your study design with input from
the people at the heart of your study.

Patient panels & interviews

Go beyond data to discover the lived
experiences and needs of your patients.

Our enrollment benchmarking identifies your enrollment gaps, and our solutions
for patient and site input helps close them.

How clients leverage our patient
and site perspectives

Published in scientific reports

Our data was used as part of a self-evaluation of 20,000 migraine patients.

Innovating study review processes

Supporting Bayer's 360 study review process

logo
Breaking down study barriers

Insights from 6,000 patients across nine countries with Regeneron

Latest content from our enrollment feasibility insights

Get in touch

Tell us about your trial and a Clariness specialist will be in touch within one business day.